Key Take Away:
Learn how to minimize the chance of receiving an FDA Warning Letter, what to doing during and after an FDA compliance audit to avoid common areas for critical mistakes.
FDA Warning Letters and recent high-profile recalls indicate major cGMP training deficiencies in many companies.
Why Should You Attend:
Targeted cGMP issues. How can a company proactively minimize the chance of receiving a Warning Letter? Areas a company "must review" beforehand. What to doing during an FDA compliance audit training?
What to do immediately after the audit? What to do during the response period. Lessons learned.
Areas Covered In This Webinar:
- The U.S. FDA's new aggressive implementation plans
- Proactive reviews of the applicable U.S. FDA / cGMP guidelines
- Key areas to focus limited resources
- FDA Inspectional objectives
- Common areas for critical mistakes
- Recent trends and events
- The compliance audit
Who Will Benefit:
- Senior Management
- Project Leaders
- Regulatory Affairs
- Quality Systems Personnel
- Internal and Supplier Auditor Personnel
- R&D and Engineering Staff
- CAPA and P&PC Personnel
- Speakers Profile:
John E. Lincoln
John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 33 years' experience in U.S. FDA regulated industries, 19 of which are as an independent consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D).
For more detail please click on this below link:
Toll Free: +1- 844-414-1400
Contact the event managers listed below for more information about how you can participate at the Avoid Warning Letters in View of the U.S. FDA's Stated Goal - By AtoZ Compliance.
|Conference/Event Dates:||07/19/2016 - 07/19/2016|
|Primary Industry:||Healthcare General|
|Other Industries:||Healthcare General, Professional Healthcare|
|Cost to Attend:||Live Webinar- $155.00 for one participant|
Quality Systems Personnel
Internal and Supplier Auditor Personnel
R&D and Engineering Staff
CAPA and P&PC Personnel
|Show Owner:||AtoZ Compliance|
|Sponsorship Details:||AtoZ Compliance|
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.